Clinical Context
Peer-reviewed veterinary literature continues to shape everyday decision-making for production animal practice, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated
A study published in Frontiers in neurology in 2025 evaluated dual antiplatelet therapy use after non-cardioembolic ischemic stroke or transient ischemic attack: a meta-analysis of trials and cohort studies..
Key Findings
Recurrent stroke burden exceeds 10% within the first year. Dual antiplatelet therapy (DAPT) is recommended for short-term secondary prevention after non-cardioembolic high-risk TIA or ischemic stroke (nc-IS), yet uncertainty persists regarding its true efficacy, optimal timing, duration, regimen, and bleeding risk. To evaluate the efficacy and safety of DAPT vs. single antiplatelet therapy (SAPT) after TIA or nc-IS and to identify clinical and study-level effect modifiers. PubMed, Embase, and Scopus were searched through October 13, 2025, for randomized trials (RTs) and cohort studies comparing DAPT and SAPT in adults (≥18 years) with TIA or...
Why It Matters for Veterinary Professionals
For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for production animal practice.
Practical Interpretation
The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.
Clinical Takeaway
Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.
Read the full article here.
List
Add
Please enter a comment